Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Gfsa Industria De Alimentação Animal Ltda has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This active matter is assigned to 1 distinct examiner working within 1 distinct art unit. The focus on this technology area reflects the company's specialized interest in biological or pharmaceutical innovations. Practitioners should focus on the specific examination patterns of this individual and art unit. The presence of 1 distinct examiner suggests that the prosecution strategy can be highly personalized to the preferences of that examiner.
The busiest examiner for this portfolio is HUANG, GIGI GEORGIANA, who is currently managing 1 pending office action. This single action constitutes the total pending workload for the company. Because there is only 1 distinct examiner and 1 distinct art unit, the prosecution process is streamlined. The workload of 1 busiest examiner pending 1 matter suggests a highly targeted patent strategy. This centralized environment allows the company to dedicate its resources to a single set of office action responses. The lack of diversity in art units ensures that the technical arguments remain within a consistent regulatory framework at the patent office.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HUANG, GIGI GEORGIANA | 1 | 31.8% | +30.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18358886 | USE OF AN EMULSIFIER DERIVED FROM RICINOLEIC ACID TO INCREASE THE ABSORPTION OF CALCIUM AND PHOSPHORUS IN THE DIGESTIVE TRACT OF FARM ANIMALS | HUANG, GIGI GEORGIANA | — |
| Art Unit | Apps |
|---|---|
| 1613 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18358886 | USE OF AN EMULSIFIER DERIVED FROM RICINOLEIC ACID TO INCREASE THE ABSORPTION OF CALCIUM AND PHOSPHORUS IN THE DIGESTIVE TRACT OF FARM ANIMALS | HUANG, GIGI GEORGIANA | 1613 | §102§103§112DP | Non-Final OA | — | Pending | Jul 25, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialGfsa Industria De Alimentação Animal Ltda has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Gigi Georgiana Huang has the most, with 1 of Gfsa Industria De Alimentação Animal Ltda's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
